[email protected]

国际临床研究杂志

International Journal of Clinical Research

您当前位置:首页 > 精选文章

International Journal of Clinical Research. 2022; 6: (8) ; 10.12208/j.ijcr.20220352 .

Clinical effect of continuous blood purification on severe pancreatitis
连续性血液净化治疗重症胰腺炎的临床效果观察

作者: 任艳艳 *

镇江市第一人民医院 江苏镇江

*通讯作者: 任艳艳,单位:镇江市第一人民医院 江苏镇江;

收录截图(CNKI-Scholar)

引用本文: 任艳艳 连续性血液净化治疗重症胰腺炎的临床效果观察[J]. 国际临床研究杂志, 2022; 6: (8) : 28-31.
Published: 2022/9/14 14:45:11

摘要

目的 研究连续性血液净化治疗重症胰腺炎的临床效果。方法 选择2021年12月-2022年07月到本院治疗重症胰腺炎患者共72例作为观察对象,随机分为实验和对照两组,分析不同治疗方式的效果。结果 实验组血流动力学指标均优于对照组(P<0.05);治疗前,两组炎性因子(IL-6、TNF-a、IL-1、IL-8)、APACHEII评分对比(P>0.05);治疗后,实验组炎性因子(IL-6、TNF-a、IL-1、IL-8)水平与APACHEII评分低于对照组(P<0.05);实验组不良反应发生率4/36(11.11%)明显低于对照组15/36(41.67%)(P<0.05)。结论 运用连续性血液净化治疗重症胰腺炎安全性和疗效均比较高,可推广运用。

关键词: 连续性血液净化;重症胰腺炎;炎性因子;APACHEII评分;不良反应

Abstract

Objective:: To study the clinical effect of continuous blood purification on severe pancreatitis.
Methods: a total of 72 patients with severe pancreatitis treated in our hospital from December 2021 to July 2022 were randomly divided into experimental and control groups to analyze the effects of different treatment methods.
Results: the hemodynamic indexes of the experimental group were better than those of the control group (P < 0.05); Before treatment, the inflammatory factors (IL-6, TNF-a, IL-1, IL-8) and APACHE II scores of the two groups were compared (P > 0.05); After treatment, the levels of inflammatory factors (IL-6, TNF-a, IL-1, IL-8) and APACHE II scores in the experimental group were lower than those in the control group (P < 0.05); The incidence of adverse reactions in the experimental group (4 / 36) (11.11%) was significantly lower than that in the control group (15 / 36) (41.67%) (P < 0.05).
Conclusion  : continuous blood purification is safe and effective in the treatment of severe pancreatitis, which can be popularized.

Key words: Continuous Blood Purification; Severe Pancreatitis; Inflammatory Factors; APACHE II Score; Adverse Reaction

参考文献 References

[1] 谢海燕,郭宁宁,王晓一. 连续性血液净化治疗重症胰腺炎患者的临床护理干预[J]. 国际移植与血液净化杂志,2020,18(1):28-30. 

[2] 常娜,霍继浩,宋涛涛,等. 连续性肾脏替代疗法联合乌司他丁对重症急性胰腺炎患者凝血功能、炎性因子及免疫屏障功能的影响[J]. 国际移植与血液净化杂志,2022, 20(1):1-4. 

[3] 周秩峤. 连续性血液净化治疗重症急性胰腺炎合并多器官功能障碍的临床效果分析[J]. 世界复合医学,2022,8(2):31-34,53. 

[4] 周帮兵,何冠. 清胰汤加减联合连续性血液净化辅助治疗腑实热结型重症急性胰腺炎(SAP)合并多器官功能障碍的疗效[J]. 养生保健指南,2022(26):61-64. 

[5] 姬杏丹. 血浆置换辅助DCRRT治疗重症急性胰腺炎患者的预后研究[J]. 四川生理科学杂志,2022, 44(4): 574-576,752. 

[6] 丘文凤,廖金明,吴洁,等. 早期连续性血液净化联合腹腔微创穿刺引流对重症急性胰腺炎腹内压、肝功能及炎症因子的影响[J]. 中国现代医学杂志,2022,32(9):91-96. 

[7] 王岩,刘洪喜. 肠内营养支持联合血液净化治疗重症胰腺炎的疗效分析[J]. 现代医学与健康研究(电子版), 2022, 6(13):127-130. 

[8] 韩冬冬. 观察连续性血液净化(CBP)对重症急性胰腺炎(SAP)合并多器官功能障碍综合征(MODS)患者血清炎症介质的影响[J]. 保健文汇,2022,23(3):126-127. 

[9] 张符林. 高脂血症性重症急性胰腺炎患者行血浆置换术治疗的疗效分析[J]. 中国药物与临床,2 022, 22(4): 366-369. 

[10] 宁春凤,黄金珊,玉春润. ICU重症患者连续性血液净化的临床护理进展研究[J]. 自我保健,2022(7):284-286.